Abstract
Overall, cancers of the endocrine system comprise a small percentage (3%) of all cancer cases. The overwhelming majority of which are thyroid cancer (95%). The majority of the nonthyroid cancers are rare, defined as fewer than 6 cases per 100, 000 people per year. This chapter on malignancy-associated endocrine disorders examines the laboratory tests, as well as the epidemiology, risk and hereditary factors, pathology, clinical features, and additional diagnostic tests for cancers of the endocrine system with a focus on multiple endocrine syndromes, gastrointestinal neuroendocrine tumors, adrenal tumors, neuroblastoma, pheochromocytoma, parathyroid tumors, and thyroid tumors.
Original language | English (US) |
---|---|
Title of host publication | Handbook of Diagnostic Endocrinology |
Publisher | Elsevier |
Pages | 449-475 |
Number of pages | 27 |
ISBN (Electronic) | 9780128182772 |
DOIs | |
State | Published - Jan 1 2020 |
Keywords
- Adrenocortical carcinoma
- Carcinoma
- Gastrinoma
- Glucagonoma
- Insulinoma
- Malignancy
- Multiple endocrine neoplasia
- Neuroblastoma
- Parathyroid
- Pheochromocytoma
- Thyroid
- Vipoma
ASJC Scopus subject areas
- General Medicine